Baxter's $4B buyout of Gambro gets OK from Australian regulators

09/6/2013 | MassDevice.com (Boston)

Baxter's acquisition of Gambro, a Swedish maker of dialysis systems, for almost $4 billion has won approval from business regulators in Australia. The decision is contingent on Baxter divesting itself of its renal replacement therapy unit. The acquisition also has the green light from regulators in the U.S., Europe, Canada, Turkey, Ukraine, Brazil, South Korea and China.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC